Immunicum

Immunicum changes name to Mendus

The biotechnology company formerly known as Immunicum is now operated and traded under the name Mendus. The company, which develops immunotherapies for cancer patients with...

News roundup Thursday, June 23

The latest from BioStock

News roundup Thursday, June 9

BioStock Life Science Spring Summit

News roundup Wednesday June 1

BioStock Life Science Spring Summit

Immunicum delivers positive phase II data in AML

The Swedish-Dutch biotechnology company Immunicum has taken big steps...

News roundup Monday, May 16

BioStock Life Science Spring Summit

News roundup Wednesday, May 11

BioStock Life Science Spring Summit

Immunicum presents data for potential AML treatment

Acute myeloid leukemia has one of the highest...

News roundup Thursday, May 5

BioStock Life Science Spring Summit

News roundup Wednesday, May 4

BioStock Life Science Spring Summit

News roundup Thursday, April 28

MOT South

Immunicum participates in new cancer research consortium

In an effort to provide patients with faster access...